Marinus Pharmaceuticals, Inc. (MRNS)
NASDAQ: MRNS · Real-Time Price · USD
0.230
-0.009 (-3.56%)
At close: Dec 20, 2024, 4:00 PM
0.233
+0.003 (1.39%)
After-hours: Dec 20, 2024, 5:36 PM EST
Marinus Pharmaceuticals Employees
As of December 31, 2023, Marinus Pharmaceuticals had 166 total employees, including 165 full-time and 1 part-time employees. The number of employees increased by 13 or 8.50% compared to the previous year.
Employees
166
Change (1Y)
13
Growth (1Y)
8.50%
Revenue / Employee
$189,554
Profits / Employee
-$846,331
Market Cap
12.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cosmos Health | 123 |
STRATA Skin Sciences | 99 |
Ekso Bionics Holdings | 72 |
Aspira Women's Health | 64 |
Sol-Gel Technologies | 36 |
Imunon | 33 |
Brainstorm Cell Therapeutics | 29 |
AIM ImmunoTech | 28 |
MRNS News
- 5 weeks ago - Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results - Business Wire
- 2 months ago - Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives - Business Wire
- 2 months ago - Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting - Business Wire
- 2 months ago - 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity - Benzinga
- 2 months ago - Marinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration Regimens - Business Wire
- 2 months ago - Marinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual Meeting - Business Wire
- 2 months ago - Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
- 2 months ago - Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech? - Benzinga